Vaccines
News
Prime-boost flu vaccination strategy effective in children
Key clinical point: A prime-boost flu vaccination strategy was found effective in children and adolescents. Major finding: Compared with no...
Conference Coverage
ACR: Don’t give pneumococcal vaccine to CAPS, Behçet’s patients
Pneumococcal vaccines can trigger severe local and systemic inflammatory reactions in patients with cryopyrin-associated periodic syndromes,...
Conference Coverage
Shingles vaccine protection lasted about 5 years in autoimmune disease patients
Protection against shingles appeared to wane 5 years after patients with autoimmune diseases received the live herpes zoster vaccine.
News
Afghanistan still struggling with poliovirus
Afghanistan experienced a “major setback” in its efforts to eradicate polio in 2014, after having made significant progress towards elimination of...
News
Improved supply chain, immunization rates key to global vaccination success
The key element to achieving global vaccination coverage goals may be improving vaccine stock management, suggests a recent report by the Centers...
Conference Coverage
Staphylococcus aureus vaccine tolerable, immunogenic in preliminary study
Key clinical point: A four-antigen vaccine against Staphylococcus aureus yielded durable functional antibody responses and no major safety signals...
News
Progress toward measles elimination slows
The number of global measles incidences declined and measles vaccine coverage increased between 2000 and 2010, but progress toward eliminating the...
Conference Coverage
Shingles vaccine protection lasted 5-6 years in autoimmune disease patients
Key clinical point: Protection against shingles appeared to wane between the fifth and sixth years after patients with autoimmune diseases...
News
Quadrivalent HPV vaccine treats recalcitrant warts in preadolescent children
A quadrivalent human papillomavirus vaccine was effective at removing therapy-resistant warts from children aged 9-11 years.
News
Genomic sequencing technology reveals weakness in malaria vaccine
Genetic variability in the surface protein targeted by an experimental malaria vaccine explains why the vaccine provided only moderate protection...